Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Income from Continuing Operations (2016 - 2025)

Aethlon Medical filings provide 15 years of Income from Continuing Operations readings, the most recent being 1910047.0 for Q1 2025.

  • On a quarterly basis, Income from Continuing Operations rose 20.63% to 1910047.0 in Q1 2025 year-over-year; TTM through Mar 2025 was 9043243.0, a 25.81% increase, with the full-year FY2025 number at 9053352.0, up 25.84% from a year prior.
  • Income from Continuing Operations hit 1910047.0 in Q1 2025 for Aethlon Medical, down from 1754783.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1754783.0 in Q4 2024 to a low of 3785698.0 in Q1 2022.
  • Median Income from Continuing Operations over the past 5 years was 2571440.0 (2024), compared with a mean of 2694480.47.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 82.46% in 2022 and later surged 49.37% in 2024.
  • Aethlon Medical's Income from Continuing Operations stood at 2527946.0 in 2021, then fell by 12.73% to 2849753.0 in 2022, then fell by 21.63% to 3466121.0 in 2023, then soared by 49.37% to 1754783.0 in 2024, then dropped by 8.85% to 1910047.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1910047.0 (Q1 2025), 1754783.0 (Q4 2024), and 2806973.0 (Q3 2024) per Business Quant data.